Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Usefulness of Cerebrolysin in Alleviating the Severity of Delirium in Critically Ill Patients

NCT06677502 is registered in ClinicalTrials.gov with Medical University of Lublin as lead sponsor.

NCT NCT06677502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06677502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Usefulness of Cerebrolysin in Alleviating the Severity of Delirium in Critically Ill Patients
Lead sponsor
Medical University of Lublin
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 1, 2024
Completion date
December 31, 2025
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment